Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-10-25 4:30 pm Purchase | 13G | Kintara Therapeutics Inc. KTRA | Theofilos Charles Steve | 2,506,321 5.900% | 2,506,321 (New Position) | View |
| 2024-06-18 4:15 pm Purchase | 13D | Akari Therapeutics Plc AKTX | Theofilos Charles Steve | 2,370,750,000 9.990% | 2,370,750,000 (New Position) | View |
| 2024-06-07 4:33 pm Sale | 13D | electroCore Inc. ECOR | Theofilos Charles Steve | 418,713 6.500% | -219,220 (-34.36%) | View |
| 2023-12-18 4:10 pm Unchanged | 13D | electroCore Inc. ECOR | Theofilos Charles Steve | 637,933 9.900% | 0 (Unchanged) | View |
| 2023-12-07 07:53 am Purchase | 13G | electroCore Inc. ECOR | Theofilos Charles Steve | 637,933 9.900% | 637,933 (New Position) | View |